Factor XIII concentrate, human (Corifact)

From HemOnc.org - A Hematology Oncology Wiki
Revision as of 06:40, 13 May 2012 by Dryang (talk | contribs) (Text replace - "or the prescribing information<ref name="insert"></ref>." to "or the prescribing information.<ref name="insert"></ref>")
Jump to navigation Jump to search

Also known as coagulation factor 13, FXIII.

General information

Class/mechanism: Human factor XIII; in the coagulation cascade, factor XIII is activated by thrombin (factor IIa) to factor XIIIa, which promotes cross-linking of fibrin. Factor XIIIa promotes stabilization of the fibrin clot by cross-linking alpha-2 plasmin inhibitor to the alpha chain of fibrin. Clinically used in patients with congenital factor XIII deficiency.[1][2][3]
Route: IV
Extravasation: no information

For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]

Patient drug information

References

  1. ↑ 1.0 1.1 Factor XIII concentrate, human (Corifact) package insert
  2. ↑ Factor XIII concentrate, human (Corifact) package insert (locally hosted backup)
  3. ↑ Corifact manufacturer's website
  4. ↑ Factor XIII concentrate, human (Corifact) package insert PDF page 5
  5. ↑ Factor XIII concentrate, human (Corifact) patient drug information (UpToDate)
Retrieved from "https://hemonc.org/w/index.php?title=Factor_XIII_concentrate,_human_(Corifact)&oldid=1484"